OTC Markets Group

Lleida.net reaches 200 patents with three new recognitions in Canada and Taiwan

Retrieved on: 
Monday, February 1, 2021
Intangible assets, Monopoly, Intellectual property law, Patent law, Intellectual property, OTC Markets Group, Patent portfolio, Patent, Euronext, Articles, Cognition, The arts

These two patents are key for the certification service to be offered by telecommunication operators and postal operators in Canada, as Lleida.net's services are already offered in countries such as the United Arab Emirates or Colombia.

Key Points: 
  • These two patents are key for the certification service to be offered by telecommunication operators and postal operators in Canada, as Lleida.net's services are already offered in countries such as the United Arab Emirates or Colombia.
  • "For us, the fact that in just a few years our intellectual property portfolio has grown to 200 patents sends a clear message to our investors," explained Sisco Sapena, CEO and founder of the company."
  • Investment in intellectual property has given the company decades of rights to exploit its technology in more than 50 countries on five continents.
  • The company is listed on the OTCQX in New York, BME Growth in Madrid and Euronext Growth in Paris.

Plurilock Announces Non-Brokered Private Placement

Retrieved on: 
Friday, January 29, 2021
OTC Markets Group

Victoria, British Columbia--(Newsfile Corp. - January 29, 2021) - Plurilock Security Inc. (TSXV: PLUR) (OTCQB: PLCKF) ("Plurilock" or the "Company"), an innovative cybersecurity company that provides frictionless and continuous authentication, announced today that it is conducting a non-brokered private placement of 5,555,555 units of the Company (collectively, the "Units") at a price of C$0.45 per Unit for aggregate gross proceeds of approximately $2,500,000 (the "Offering").

Key Points: 
  • Victoria, British Columbia--(Newsfile Corp. - January 29, 2021) - Plurilock Security Inc. (TSXV: PLUR) (OTCQB: PLCKF) ("Plurilock" or the "Company"), an innovative cybersecurity company that provides frictionless and continuous authentication, announced today that it is conducting a non-brokered private placement of 5,555,555 units of the Company (collectively, the "Units") at a price of C$0.45 per Unit for aggregate gross proceeds of approximately $2,500,000 (the "Offering").
  • The securities issued pursuant to the Offering will be subject to a four-month hold period from the closing date.
  • Plurilock is an innovative, identity-centric cybersecurity company that reduces or eliminates the need for passwords, extra authentication steps, and cumbersome authentication devices.
  • Plurilock enables organizations to compute safely-and with peace of mind.

Laura Bastias Appointed Independent Director

Retrieved on: 
Friday, January 29, 2021
OTC Markets Group, Turmalina

VANCOUVER, British Columbia, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Turmalina Metals Corp. (Turmalina, or the Company; TBX-TSXV, TBXXF-OTCQX) is pleased to announce that Laura Bastias will join the board of the company as an independent director.

Key Points: 
  • VANCOUVER, British Columbia, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Turmalina Metals Corp. (Turmalina, or the Company; TBX-TSXV, TBXXF-OTCQX) is pleased to announce that Laura Bastias will join the board of the company as an independent director.
  • Ms Bastias is a highly respected San Juan-based lawyer with extensive experience in mining and corporate law.
  • Her knowledge of the local mining, permitting and corporate environment is remarkable, and her balanced perspective will serve her well as an independent director.
  • Following the appointment of Ms Bastias the Board of Turmalina is as follows:
    On Behalf of the Company,
    Dr. Rohan Wolfe, Chief Executive Officer and Director.

Wavefront Announces First Quarter 2021 Financial Results

Retrieved on: 
Friday, January 29, 2021
Economy of Toronto, OTC Markets Group, Wavefront Technology Solutions, Toronto Stock Exchange, Companies, Economy of Canada, Service companies

Edmonton, Alberta--(Newsfile Corp. - January 29, 2021) - Wavefront Technology Solutions Inc. (TSXV: WEE) (OTCQB: WFTSF) ("Wavefront" or the "Company"), an oil field service provider focused on offering the oil and gas industry proprietary, leading edge technology announces its financial results for the first quarter ending November 30, 2020.

Key Points: 
  • Edmonton, Alberta--(Newsfile Corp. - January 29, 2021) - Wavefront Technology Solutions Inc. (TSXV: WEE) (OTCQB: WFTSF) ("Wavefront" or the "Company"), an oil field service provider focused on offering the oil and gas industry proprietary, leading edge technology announces its financial results for the first quarter ending November 30, 2020.
  • An overview of the financial results for the reporting period includes:
    Total recorded revenues for the first quarter 2021 (i.e., three months ended November 30, 2020) 445,760 a decrease of $254,925 from the comparative quarter (i.e., three months ended November 30, 2019) revenues of $700,685.
  • The above financial highlights should be read in conjunction with the unaudited condensed consolidated interim financial statements and management discussion and analysis of results for Wavefront for the first quarter ended November 30, 2020, which were filed on SEDAR on January 29, 2021.
  • Wavefront publicly trades on the TSX Venture Exchange under the symbol WEE and on the OTCQB under the symbol WFTSF.

First National Bank Alaska Declares Dividend For First Quarter 2021

Retrieved on: 
Friday, January 29, 2021
Banking, Professional services, Finance, Dividend, Shareholders, OTC Markets Group, Finance

At the Board of Directors Meeting held January 28, 2021, First National Bank Alaska (OTCQX:FBAK) declared a cash dividend of $3.20 per share, payable on March 15, 2021, to shareholders of record as of March 1, 2021.

Key Points: 
  • At the Board of Directors Meeting held January 28, 2021, First National Bank Alaska (OTCQX:FBAK) declared a cash dividend of $3.20 per share, payable on March 15, 2021, to shareholders of record as of March 1, 2021.
  • View source version on businesswire.com: https://www.businesswire.com/news/home/20210129005568/en/

Recruiter.com Maps Out 2021 Plan to Achieve $40M and Profitability

Retrieved on: 
Friday, January 29, 2021
Nursing, Military recruitment, Recruitment, OTC Markets Group, Employment, Labor, Articles

HOUSTON, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Recruiter.com (OTCQB:RCRT) released its January 2021 Shareholder Letter highlighting its 2020 accomplishments and outlining its plans to achieve $40M in run-rate revenue along with profitability.

Key Points: 
  • HOUSTON, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Recruiter.com (OTCQB:RCRT) released its January 2021 Shareholder Letter highlighting its 2020 accomplishments and outlining its plans to achieve $40M in run-rate revenue along with profitability.
  • In 2020, we helped top companies find call center operators, nurses, mortgage professionals, IT engineers, and even a rocket scientist.
  • We also helped our network of small and independent recruiters earn thousands of dollars in fees during a year when the recruiting industry was hit hard.
  • All Recruiter.com On Demand gig recruiters have access to the Recruiter.com AI and Video platforms to improve their success rates.

PURA and USMJ Enter Strategic Negotiations

Retrieved on: 
Friday, January 29, 2021
OTC Markets Group, Cannabis, Branches of biology

Dallas, Texas--(Newsfile Corp. - January 29, 2021) - Puration, Inc. (OTC Pink: PURA) and North American Cannabis Holdings, Inc. (OTC Pink: USMJ) today announced entering strategic negotiations.

Key Points: 
  • Dallas, Texas--(Newsfile Corp. - January 29, 2021) - Puration, Inc. (OTC Pink: PURA) and North American Cannabis Holdings, Inc. (OTC Pink: USMJ) today announced entering strategic negotiations.
  • USMJ runs a cannabis ecommerce business that includes a cannabis products logistics operation.
  • Toward this end, PURA has already established partnerships with Alkame Holdings, Inc. (OTC Pink: ALKM) and PAO Group, Inc. (OTC Pink: PAOG).
  • Today, PURA and USMJ make their co-development plans public for the first time.

Fentura Financial, Inc. Announces Quarterly Dividend

Retrieved on: 
Friday, January 29, 2021
Dividend, Shareholders, OTC Markets Group

FENTON, Mich., Jan. 29, 2021 (GLOBE NEWSWIRE) -- Fentura Financial, Inc. (OTCQX: FETM) has announced a regular dividend of $0.08 per share for shareholders of record as of February8, 2021, and payable February15, 2021.

Key Points: 
  • FENTON, Mich., Jan. 29, 2021 (GLOBE NEWSWIRE) -- Fentura Financial, Inc. (OTCQX: FETM) has announced a regular dividend of $0.08 per share for shareholders of record as of February8, 2021, and payable February15, 2021.
  • Fentura Financial, Inc. is the holding company for The State Bank.
  • The State Bank is a full-service, 5-Star Bauer Financial rated commercial, retail and trust bank headquartered in Fenton, Michigan.
  • Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release.

Orexo expects FDA filing of OX124 mid 2022

Retrieved on: 
Friday, January 29, 2021
Drugs, Psychoactive drugs, Euphoriants, Medical emergencies, Morphinans, Opioids, Morphine, Fentanyl, Naloxone, Opioid overdose, Drug overdose, OTC Markets Group

),(STO: ORX) (OTCQX: ORXOY) today announces that it is expecting to file its flagship pharmaceutical pipeline asset OX124 with the US Food and Drug Administration mid-2022.

Key Points: 
  • ),(STO: ORX) (OTCQX: ORXOY) today announces that it is expecting to file its flagship pharmaceutical pipeline asset OX124 with the US Food and Drug Administration mid-2022.
  • Based on Orexo's patent-protected nasal delivery technology, OX124 is a powerful naloxone rescue medication, designed to reverse opioid overdoses, including those from synthetic opioids, such as fentanyl.
  • Orexo develops improved pharmaceuticals and digital therapies addressing unmet needs within the growing space of substance use disorders and mental health.
  • Orexo is listed on the Nasdaq Stockholm Mid Cap (ORX) and is available as ADRs on OTCQX (ORXOY) in the US.

Orexo expects FDA filing of OX124 mid 2022

Retrieved on: 
Friday, January 29, 2021
Drugs, Psychoactive drugs, Euphoriants, Medical emergencies, Morphinans, Opioids, Morphine, Fentanyl, Naloxone, Opioid overdose, Drug overdose, OTC Markets Group

),(STO: ORX) (OTCQX: ORXOY) today announces that it is expecting to file its flagship pharmaceutical pipeline asset OX124 with the US Food and Drug Administration mid-2022.

Key Points: 
  • ),(STO: ORX) (OTCQX: ORXOY) today announces that it is expecting to file its flagship pharmaceutical pipeline asset OX124 with the US Food and Drug Administration mid-2022.
  • Based on Orexo's patent-protected nasal delivery technology, OX124 is a powerful naloxone rescue medication, designed to reverse opioid overdoses, including those from synthetic opioids, such as fentanyl.
  • Orexo develops improved pharmaceuticals and digital therapies addressing unmet needs within the growing space of substance use disorders and mental health.
  • Orexo is listed on the Nasdaq Stockholm Mid Cap (ORX) and is available as ADRs on OTCQX (ORXOY) in the US.